AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 52 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $134,000 | -23.4% | 15,006 | 0.0% | 0.10% | -26.1% |
| Q3 2020 | $175,000 | -27.4% | 15,006 | 0.0% | 0.14% | -18.3% |
| Q2 2020 | $241,000 | +186.9% | 15,006 | 0.0% | 0.17% | +103.6% |
| Q1 2020 | $84,000 | -51.4% | 15,006 | +14.4% | 0.08% | -28.4% |
| Q4 2019 | $173,000 | – | 13,113 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,283,966 | $15,166,000 | 1.40% |
| Sio Capital Management, LLC | 591,870 | $3,930,000 | 0.98% |
| TFG Asset Management GP Ltd | 2,500,000 | $16,600,000 | 0.90% |
| Ikarian Capital, LLC | 1,356,048 | $9,004,000 | 0.73% |
| SABBY MANAGEMENT, LLC | 400,050 | $2,656,000 | 0.37% |
| Nantahala Capital Management | 1,793,500 | $11,909,000 | 0.34% |
| Regency Capital Management Inc.\DE | 57,000 | $378,000 | 0.29% |
| Eversept Partners, LP | 473,074 | $3,141,211 | 0.21% |
| MYDA Advisors LLC | 85,000 | $564,000 | 0.14% |
| Henry James International Management Inc. | 54,047 | $359,000 | 0.10% |